205672-19-1 Usage
Uses
Used in Pharmaceutical Development:
4-Benzyloxy-5-Bromo-2-Chloropyrimidine is used as a key intermediate in the synthesis of various drug molecules, particularly in the development of new pharmaceuticals. Its unique structure and functional groups contribute to the creation of novel compounds with potential therapeutic applications.
Used in Organic Synthesis:
Due to its highly reactive nature, 4-Benzyloxy-5-Bromo-2-Chloropyrimidine is used as a versatile building block in organic synthesis. The presence of halogens bromine and chlorine allows for various chemical reactions, enabling the formation of a wide range of organic compounds for different applications.
Used in Research Applications:
In the field of research, 4-Benzyloxy-5-Bromo-2-Chloropyrimidine serves as an important compound for studying the properties and reactions of pyrimidine derivatives. Its unique structure and functional groups provide valuable insights into the development of new synthetic methods and the exploration of novel chemical reactions.
Used in Chemical Intermediates Production:
4-Benzyloxy-5-Bromo-2-Chloropyrimidine is used as a chemical intermediate in the production of other organic compounds. Its reactivity and functional groups make it a valuable precursor for the synthesis of various chemical products, including pharmaceuticals, agrochemicals, and other specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 205672-19-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,5,6,7 and 2 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 205672-19:
(8*2)+(7*0)+(6*5)+(5*6)+(4*7)+(3*2)+(2*1)+(1*9)=121
121 % 10 = 1
So 205672-19-1 is a valid CAS Registry Number.
InChI:InChI=1/C11H8BrClN2O/c12-9-6-14-11(13)15-10(9)16-7-8-4-2-1-3-5-8/h1-6H,7H2
205672-19-1Relevant articles and documents
Studies on the synthesis of the derivatives of 5-(dihydroxyboryl)-cytosines and -isocytosines
Wojtowicz-Rajchel, Hanna,Suchowiak, Marek,Fiedorow, Piotr,Golankiewicz, Krzysztof
, p. 841 - 845 (2007/10/03)
Boron derivatives of isocytosine, containing a dihydroxyboryl group in the 5-position, have been prepared for the first time. Reaction of appropriate pyrimidines with n-butyllithium and subsequent boronation at -100°C with triethylborate, followed by catalytic hydrogenation, gave hydrolytically stable N,N-dimethyl-5-(dihydroxyboryl)isocytosine 8a and N-methyl-5-(dihydroxyboryl)isocytosine 8b. Theoretical calculations suggest that the corresponding boron derivatives of cytosine cannot be obtained as thermodynamically stable compounds.
